End Cash: The amount of cash held by the company for the given period.
Better Therapeutics, Inc. (BTTX) had End Cash of $6.60M for the most recently reported fiscal quarter, ending 2023-09-30.
| Income Statement Financials | |
-- |
|
$-5.86M |
|
-- |
|
-- |
|
$5.34M |
|
$-5.34M |
|
$-0.52M |
|
$-5.86M |
|
$-5.86M |
|
$-5.86M |
|
$-5.86M |
|
$-5.86M |
|
$-5.86M |
|
$-5.34M |
|
$-4.50M |
|
38.49M |
|
38.49M |
|
$-0.15 |
|
$-0.15 |
|
| Balance Sheet Financials | |
$7.34M |
|
$0.10M |
|
$3.38M |
|
$10.72M |
|
$12.94M |
|
$7.72M |
|
$7.72M |
|
$20.66M |
|
$-9.94M |
|
$-9.94M |
|
$-9.94M |
|
40.58M |
|
| Cash Flow Statement Financials | |
$-19.75M |
|
$-0.96M |
|
$11.56M |
|
$15.74M |
|
|
End Cash |
$6.60M |
$-9.14M |
|
$1.31M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.57 |
|
-- |
|
-- |
|
-3.48 |
|
-1.44 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-20.70M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
58.99% |
|
58.99% |
|
-54.67% |
|
264.53% |
|
$-0.24 |
|
$-0.54 |
|
$-0.51 |
|